SS Gill, GM Anderson, HD Fischer, CM Bell, … - Archives of Internal Medicine, 2009 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 6 - Related articles - All 6 versions
AA Fisher, MW Davis - The Annals of Pharmacotherapy, 2008 - Harvey Whitney Books 278 I The Annals of Pharmacotherapy I 2008 February, Volume 42 ...
Acetylcholinesterase inhibitors (AChIs) are used in treatment of mild-to-mod-
erate Alzheimer's disease.1,2 These drugs also improve cognition in ... Cited by 5 - Related articles - BL Direct - All 5 versions
LY Park-Wyllie, MM Mamdani, P Li, SS Gill, A …, 2009 - pubmedcentral.nih.gov ICMJE criteria for authorship read and met: LPW MMM PL SSG AL DNJ. Agree with
the manuscript's results and conclusions: LPW MMM PL SSG AL DNJ. Designed the
experiments/the study: LPW MMM SSG AL DNJ. Analyzed the data: LPW PL SSG. ... Cited by 2 - Related articles - All 4 versions
DB Hogan - Neuropsychiatric Disease and Treatment, 2007 - pubmedcentral.nih.gov A number of drugs have been approved for the treatment of Alzheimer's disease
(AD) and a larger number are being studied as possible therapies. The current
mainstays of the pharmacotherapy of AD are the cholinesterase inhibitors ( ... Cited by 2 - Related articles - BL Direct - All 7 versions
E Poluzzi, E Raschi, U Moretti, F De Ponti - Pharmacoepidemiology and Drug Safety, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 2 - Related articles - All 3 versions
H Förstl - Der Internist, 2008 - Springer Da die Alzheimer-Demenz (AD) als häu- figste Demenzform gilt, werden die An-
tidementiva zunächst meist zur Behand- lung der AD geprüft und dafür zugelas-
sen. In Wirklichkeit handelt es sich bei den meisten Demenzen im Senium je- ... Cited by 2 - Related articles - All 2 versions
LY Park-Wyllie, MM Mamdani, P Li, SS Gill, A …, 2009 - bioknow.cn Laura Y. Park-Wyllie1,2,3*, Muhammad M. Mamdani2,3,4,5, Ping Li3, Sudeep S.
Gill3,6, Andreas Laupacis2,3,5,7, David N. Juurlink3,5,7,8 1 Department of
Family and Community Medicine, St. Michael's Hospital, Toronto, Ontario, ... Related articles - View as HTML - All 3 versions
D Maliepaard, T MacEwan - International Psychogeriatrics, 2009 - Cambridge Univ Press International Psychogeriatrics (2009), 21:3, 457–462 C 2009 International
Psychogeriatric Association doi:10.1017/S1041610209008953 Printed in the United
Kingdom ... Cardiac monitoring for cholinesterase inhibitors: a survey Related articles - All 2 versions
A Gehi, M Benatar, J Langberg - Journal of Cardiovascular Electrophysiology, 2008 - interscience.wiley.com Myasthenia gravis is an autoimmune disorder of the nervous system typically
mediated by antibodies against the nicotinic acetylcholine receptor at the
neuromuscular junction. Treatment of myasthenia gravis frequently involves ... Related articles - BL Direct - All 4 versions
Å Reikvam, U i Oslo, MOG VITENSKAP - test.tidsskriftet.no Bakgrunn. En rekke randomiserte studier, for det meste av kort varighet, har
indikert at kolinesterasehemmere (donepezil, rivastigmin og galantamin) kan ha
en viss gunstig effekt ved Alzheimers sykdom, ved vaskulær demens og ved ... Related articles - Cached - All 4 versions
